CIK 0001001233
- Non-accelerated filer
- Smaller reporting company
SANGAMO THERAPEUTICS, INC
Sign in to watch- Ticker
- SGMOQ
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680359556
- Phone
- +1 510-970-6000
- Business address
- 501 CANAL BLVD., RICHMOND, CA, 94084
- Former names
- SANGAMO BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-24 | Willoughby Scott B. SVP, CHIEF LEGAL OFFICER, SECY | Shares withheld for taxes | −1,650 | $0.47 | $780 | 663,760 |
| 2026-02-24 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −5,291 | $0.47 | $2K | 1,941,293 |
| 2026-01-22 | Jain Nikunj Principal Accounting Officer | Shares withheld for taxes | −7,721 | $0.40 | $3K | 242,996 |
| 2026-01-22 | Davis Gregory D Head of Research & Technology | Shares withheld for taxes | −7,721 | $0.40 | $3K | 191,062 |
| 2026-01-22 | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | Shares withheld for taxes | −36,676 | $0.40 | $15K | 693,128 |
| 2026-01-22 | Willoughby Scott B. SVP, CHIEF LEGAL OFFICER, SECY | Shares withheld for taxes | −36,676 | $0.40 | $15K | 665,410 |
| 2026-01-22 | Duraibabu Prathyusha PRINCIPAL FINANCIAL OFFICER | Shares withheld for taxes | −36,676 | $0.40 | $15K | 660,042 |
| 2026-01-22 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −102,950 | $0.40 | $41K | 1,946,584 |
| 2025-11-24 | Jain Nikunj Principal Accounting Officer | Shares withheld for taxes | −578 | $0.42 | $241 | 245,717 |
| 2025-11-24 | Davis Gregory D Head of Research & Technology | Shares withheld for taxes | −723 | $0.42 | $301 | 193,791 |
| 2025-11-24 | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | Shares withheld for taxes | −2,544 | $0.42 | $1K | 719,804 |
| 2025-11-24 | Willoughby Scott B. SVP, CHIEF LEGAL OFFICER, SECY | Shares withheld for taxes | −2,035 | $0.42 | $848 | 702,086 |
| 2025-11-24 | Duraibabu Prathyusha PRINCIPAL FINANCIAL OFFICER | Shares withheld for taxes | −2,544 | $0.42 | $1K | 696,718 |
| 2025-11-24 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −7,488 | $0.42 | $3K | 2,049,534 |
| 2025-10-22 | Jain Nikunj Principal Accounting Officer | Shares withheld for taxes | −6,708 | $0.66 | $4K | 246,295 |
| 2025-10-22 | Davis Gregory D Head of Research & Technology | Shares withheld for taxes | −6,708 | $0.66 | $4K | 194,514 |
| 2025-10-22 | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | Shares withheld for taxes | −43,741 | $0.66 | $29K | 722,348 |
| 2025-10-22 | Willoughby Scott B. SVP, CHIEF LEGAL OFFICER, SECY | Shares withheld for taxes | −44,122 | $0.66 | $29K | 704,121 |
| 2025-10-22 | Duraibabu Prathyusha PRINCIPAL FINANCIAL OFFICER | Shares withheld for taxes | −45,225 | $0.66 | $30K | 699,262 |
| 2025-10-22 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −126,950 | $0.66 | $84K | 2,057,022 |
Page 2 of 9 · 165 trades